Leo Lens Pharma Expands Its Scientific Advisory Board

External Thought Leaders to Help Guide Progress on Company’s Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire August 5th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the expansion


Leo Lens Pharma Appoints Dan Myers CEO

Accomplished Ophthalmic Executive to Lead Company in Its Next PhaseSAN DIEGO, CA, USA (BUSINESS WIRE April 15, 2020) – Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) is pleased to announce the appointment of Dan Myers as Chief Executive Officer. Prior to joining


Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma

Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice


Recent Posts


Go to Top